At a glance
A naturally occurring tripeptide central to cellular redox chemistry.
This profile separates the compound’s scientific background from specification-specific preparation and source schedules. Begin with the research findings and limitations, then select the formulation you want to examine.
How it works
Potential benefits & side effects
Interpret each outcome in the context of the study population, formulation and evidence type. Research findings do not establish a personal treatment outcome.
Potential benefits & research findings
The source discusses oxidative-stress and other clinical markers. Normal antioxidant biology alone does not prove that a particular administration method improves health.[1][10][9]
Read the original publications to see the measured endpoints, comparator, duration and uncertainty. Mechanistic plausibility and a favorable experimental result are different from demonstrated clinical benefit.
Side effects & evidence limitations
Interpret the reported adverse effects together with the study population, route and observation period. Small or short studies can miss uncommon and delayed harms. Evidence from a related compound does not establish the safety of Glutathione.
Source-reported adverse effects and cautions
Sources are available for independent reading. Individual claims and research schedules have not yet undergone an independent clinical review by Pep Science.
- Editorial responsibility
- Pep Science editorial desk
- Last independent review
- Not yet recorded
SPECIFICATIONS & SOURCE SCHEDULES
Explore a vial size
Select the exact formulation. Vial content, target dose and prepared concentration are different measurements.
Showing 600 mg · 1 source tables
Standard / Gradual Approach (2 mL = 300 mg/mL)
| Week | Daily Dose (mg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 100 mg | 33 units (0.33 mL) |
| Weeks 3–4 | 150 mg | 50 units (0.50 mL) |
| Weeks 5–8 | 200 mg | 67 units (0.67 mL) |
Frequency: Inject once daily subcutaneously, or split into every-other-day dosing based on protocol goals[5]. Some protocols utilize 200 mg 1–2 × weekly for maintenance[6]. This schedule uses a practical 2.0 mL dilution for accurate measurements with standard insulin syringes.
Additional schedule context & duration
Concise summary of the subcutaneous regimen.
- Goal: Support antioxidant defense, cellular detoxification, and immune function[1][3].
- Schedule: Daily or every-other-day subcutaneous injections for 4–8 weeks.
- Dose Range: 100–200 mg daily with gradual titration.
- Reconstitution: 2.0 mL per 600 mg vial (300 mg/mL) for accurate unit measurements.
- Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
Suggested daily titration approach.
- Start: 100 mg daily; increase by ~50 mg every 1–2 weeks as tolerated.
- Target: 150–200 mg daily by Weeks 3–8.
- Frequency: Once per day (subcutaneous) or every other day for maintenance.
- Cycle Length: 4–8 weeks; optional cycling off for 2–4 weeks between protocols.
- Timing: Any consistent time; rotate injection sites.
Read this protocol on Pep Science → · View cited documents ↓
Preparation
Reconstitution Steps
- Draw 2.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Storage Instructions
Proper storage preserves peptide quality.
- Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
- Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use promptly and avoid freeze–thaw.
- Allow vials to reach room temperature before opening to reduce condensation uptake.
- Glutathione is relatively unstable once reconstituted—use within 2–3 weeks for optimal potency[6].
Injection Technique
General subcutaneous guidance from clinical best-practice resources[16].
- Clean the vial stopper and skin with alcohol; allow to dry.
- Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[17][18].
- Do not aspirate for subcutaneous injections; inject slowly and steadily[17].
- Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[19].
Materials & quantity planning
Source materials checklist · 600 mg
Plan based on a 4–8 week daily protocol with gradual titration.
-
Peptide Vials (Glutathione, 600 mg each):
- 4 weeks (100–150 mg/day avg) ≈ 3 vials
- 8 weeks (150–200 mg/day avg) ≈ 7 vials
-
Insulin Syringes (U-100):
- Per week: 7 syringes (1/day)
- 4 weeks: 28 syringes
- 8 weeks: 56 syringes
-
Bacteriostatic Water (10 mL bottles): Use ~2.0 mL per vial for reconstitution.
- 4 weeks (3 vials): 6 mL → 1 × 10 mL bottle
- 8 weeks (7 vials): 14 mL → 2 × 10 mL bottles
-
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
- Per week: 14 swabs (2/day)
- 4 weeks: 56 swabs → recommend 1 × 100-count box
- 8 weeks: 112 swabs → recommend 2 × 100-count boxes
Calculate a phased quantity
Enter each finite phase from the schedule you are studying. Open-ended phases need an explicit duration. Calculation uses 600 mg per vial and 2 mL per vial.
Complete each phase to calculate totals.
Quantity estimates exclude preparation losses and expiry. Follow the formulation’s handling and disposal requirements.
FOLLOW THE EVIDENCE
References & further reading
Original publications and source documents cited across this product’s variants. A listed source is not an independent endorsement of a dosing schedule.
- 01
Research publication
PubMed — The antioxidant glutathione: protective roles, cofactor functions, and regeneration mechanisms (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 02
Research publication
PubMed — Glutathione and glutathione-dependent enzymes: coordinated defense against oxidative stress (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 03
Public health resource
PMC — Glutathione: roles in immune function, detoxification, and clinical applications (opens in a new tab)www.ncbi.nlm.nih.gov
Back to overview ↑ - 04
Research publication
PubMed — The interplay of glutathione-related processes in antioxidant defense (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 05
Research publication
PMC — Exploring safety and efficacy of glutathione supplementation: narrative review (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑ - 06
Research publication
PubMed — Glutathione as a skin-lightening agent and in melasma: systematic review (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 07
Research publication
PMC — Glutathione: pharmacological aspects and implications for clinical use in NAFLD (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑ - 08
Research publication
PubMed — Oxidative stress: role of mitochondria and protection by glutathione (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 09
Research publication
PMC — Efficacy of glutathione for NAFLD treatment: open-label pilot study (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑ - 10
Research publication
PMC — Protective effect of glutathione against oxidative stress-induced cytotoxicity via Nrf2/HO-1 pathway (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑ - 11
Research publication
PubMed — Glutathione in the treatment of liver diseases: clinical practice insights (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 13
Research publication
PubMed — Clinical effect of glutathione on skin color and related conditions: systematic review (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 14
Research publication
PMC — Glutathione and its antiaging and antimelanogenic effects: RCT at 250 mg/day (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑ - 15
Research publication
PubMed — Oxidative stress and regulation of glutathione in lung inflammation (opens in a new tab)pubmed.ncbi.nlm.nih.gov
Back to overview ↑ - 16
Research publication
PMC — Subcutaneous drug injection review: pharmacologic considerations (opens in a new tab)pmc.ncbi.nlm.nih.gov
Back to overview ↑ - 17
Public health resource
CDC — Vaccine administration: subcutaneous route (angle/site; no aspiration) (opens in a new tab)www.cdc.gov
Back to overview ↑ - 18
Public health resource
CDC (Subcut Injection PDF) — Technique diagram and site guidance for subcutaneous injections (opens in a new tab)www.cdc.gov
Back to overview ↑ - 19
Public health resource
NCBI Bookshelf — Best practices for injection (asepsis, preparation, and administration) (opens in a new tab)www.ncbi.nlm.nih.gov
Back to overview ↑
COMMUNITY · EXTERNAL FORUM
Discuss Glutathione with the community
Explore member conversations and ask questions on glp1chat. Forum posts and listings are not vetted or endorsed by Pep Science, and they are not medical advice or editorial evidence.
Visit the community (opens in a new tab)Continue exploring
Related topics are not interchangeable compounds or formulations.